Vaccines

Apr 02, 2018
Pharmaceutical Technology
Accelerated development of new preventives raises challenges for efficient CMC evaluation and production.
Mar 08, 2018
By Pharmaceutical Technology Editors
GlobalData reports the need to shift away from egg-based manufacturing of vaccines in light of influenza-related deaths.
Feb 15, 2018
By Pharmaceutical Technology Editors
Fluarix Tetra has been approved for use in children aged six months and above.
Jan 04, 2018
By Pharmaceutical Technology Editors
The companies will collaborate on the development of vaccines to expand GeoVax’s cancer immunotherapy program.
Dec 14, 2017
By Pharmaceutical Technology Editors
Children with a rare brainstem-based cancer might be helped by a new immunotherapy that targets a mutated protein found exclusively in cancer cells.
Nov 15, 2017
Pharmaceutical Technology
The use of approved platform technologies can reduce the time and cost required to generate new vaccines.
Nov 15, 2017
Pharmaceutical Technology
This article explores some of the challenges, services, and technologies that go into ensuring that vaccines are properly temperature controlled and maintain product integrity for delivery to patients.
Nov 15, 2017
Pharmaceutical Technology
Despite the challenges and high cost of development, vaccine innovation is at an all-time high, as new approaches aim to improve global access.
Nov 15, 2017
Pharmaceutical Technology
Challenge trials may increase in coming years as new and improved challenge agents better emulate “natural” disease states.
Nov 10, 2017
By Pharmaceutical Technology Editors
The company expects to commercially launch the new vaccine in the US in the first quarter of 2018.
native1_300x100
lorem ipsum